VARENICLINE IN PATIENTS WITH CARDIOVASCULAR DISEASES – FRIEND OR ENEMY?
The problem of varenicline use in patients with cardiovascular diseases is discussed. Results of large clinical trials and meta-analyses with varenicline have proven its high efficacy for treatment of nicotine addiction in adults and a small number of side events. Varenicline is the main agent for p...
Saved in:
Main Authors: | Yu. V. Lukina, S. Yu. Martsevich |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2015-09-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/113 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacological Basis of the Clinical Efficacy of Varenicline Used to Facilitate Smoking Cessation
by: S. R. Gilyarevskiy
Published: (2019-03-01) -
Comparison between the role of bupropion and varenicline in the management of nicotine dependence: A prospective comparative study
by: Sphurti Pusukuri, et al.
Published: (2025-01-01) -
SMOKING AS A RISK FACTOR FOR CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 2. Advantages of quitting smoking. Strategies to quit smoking
by: O. D. Ostroumova, et al.
Published: (2018-03-01) -
Nicotine dependence and neuropsychotic effects of varenicline
by: T. M. Bukatina, et al.
Published: (2018-03-01) -
Varenicline improves motor and cognitive symptoms in early Huntington’s disease
by: McGregor A, et al.
Published: (2016-09-01)